• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

bhowden@unimelb.edu.au

Credentials


Position
Director Microbiological Diagnostic Unit
Department of Microbiology and Immunology
Education
Doctorate (Coursework)
Monash University
Bachelors Degree
Monash University
ORCID

0000-0003-0237-1473

Prof Ben Howden

Director Microbiological Diagnostic Unit
Department of Microbiology and Immunology

540 Scholarly works
107 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Predictors of unsuccessful tuberculosis treatment outcome in Bhutan: A retrospective study using comprehensive national tuberculosis surveillance data
    DOI: 10.1038/s41598-026-38023-7
  • 2026

    Journal article

    Increased risk of antimicrobial resistance in patients with cirrhosis and hepatic encephalopathy using rifaximin
    DOI: 10.1038/s41467-025-67326-y
  • 2023

    Research grants (international)

    Fleming Fund Fellowship Program: Phase II
  • 2020

    Research Contracts

    Mitigating the Threat of Antimicrobial Resistance in Pacific Island Countries
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    The Staphylococcus Aureus Network Adaptive Platform Trial
  • 2019

    Journal article

    Bridging of Neisseria gonorrhoeae lineages across sexual networks in the HIV pre-exposure prophylaxis era
    DOI: 10.1038/s41467-019-12053-4
  • 2018

    Journal article

    Increasing tolerance of hospital Enterococcus faecium to handwash alcohols
    DOI: 10.1126/scitranslmed.aar6115
Ben Howden

Latest Honours,
Awards and Fellowships


2014
Frank Fenner Award Australian Society for Microbiology
2011
Young Investigator Award (ICAAC) American Society for Microbiology
2010
Commendation Victorian Premiers Prize for Medical Research, Victoria
2008
Best research proposal on infection and immunity Royal Australasian College of Physicians CSL Fellowship

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Reply to White and Siegrist, “Multi-drug-resistant enterococcal infections: duration of combination therapy and OPAT challenges”
    DOI: 10.1128/aac.01785-25
  • 2026

    Journal article

    Uncovering bacterial pseudaminylation with pan-specific antibody tools
    DOI: 10.1038/s41589-025-02114-9
  • 2026

    Journal article

    Global dissemination of optrA-mediated linezolid resistance in enterococci
    DOI: 10.1093/jac/dkag089
  • 2026

    Journal article

    Large-scale molecular epidemiological survey of Giardia and Cryptosporidium in Victoria, Australia (2020-2024), reveals novel subtypes and outbreak-associated lineages.
    DOI: 10.1128/jcm.01558-25
  • 2026

    Journal article

    Conserved CD4 T cell staphylococcal and streptococcal epitopes enable broad-acting vaccines in mice
    DOI: 10.1038/s41564-026-02265-y
  • 2026

    Journal article

    Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance
    DOI: 10.1128/aac.01526-25
  • 2026

    Journal article

    Comparing different methods for analysing hierarchical composite endpoints: two illustrative case studies with post hoc analyses of the BALANCE (Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness) and CAMERA2 (Combination Antibiotics for methicillin-resistant Staphylococcus aureus) randomized clinical trials
    DOI: 10.1016/j.cmi.2025.11.027
  • 2026

    Journal article

    Advancing genomics for waterborne pathogen surveillance in Australia
    DOI: 10.1016/j.lanwpc.2026.101828

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224